Anti-CK8 antibodies for use in the treatment of colorectal cancers
US10533046B2 · kind B2 · utility
1Cited by
1References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 10, 2015 |
| Grant date | Jan 14, 2020 |
| Priority date | — |
| Expiry date | Oct 6, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2410/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to a human CK8 antigen peptide, an antibody, or antibody fragment thereof, or a humanized antibody, specifically binding the peptide having the amino acid sequence of SEQ ID No. 29, a fragment of CK-8. Said molecules can be used use in the detection and/or treatment of tumors whose cells express CK8 protein, in particular the peptide of sequence according to SEQ ID No.29, on their surface.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.